Salt Lake City, UT, May 11, 2017 — ProLung, Inc., the leader in innovative predictive analytics technology and non-invasive tests for lung cancer, announced today the promotion of Aaron Stout to Chief Accounting Officer. Mr. Stout previously served as the Controller for ProLung.

“We are enthusiastic about the experience Mr. Stout brings to the executive management team,” stated Steve Eror, President and CEO, ProLung. “His role and experience will be crucial as ProLung prepares to enter a phase of high growth and expansion.”

Mr. Stout comes to ProLung with more than 10 years of finance and operations experience with multiple public and privately held companies in the manufacturing and medical device industries where he has successfully raised capital in debt and equity markets.  Prior to joining ProLung, Mr. Stout was the Controller of Amedica Corp, where he served from March 2014 to April 2017 and was responsible for a wide range of financial and accounting services. He served as a Senior Financial Accountant with America First Credit Union from August 2011 to April 2014. Mr. Stout has a Masters of Professional Accounting from Weber State University.

“I can’t imagine a more exciting time to be part of ProLung,” Mr. Stout said. “I look forward to working with Steve and the entire ProLung leadership team to ensure a successful and capital-efficient business.”

About ProLung, Inc.

ProLung’s mission is to make a difference in time for lung cancer patients. ProLung is a leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients. ProLung’s predictive analytics platform for lung cancer risk stratification is approved for sale in the European Economic Area and for investigational use only in the US.

 

For further information, contact:

Ryan Snow | +1-801-503-9231 | rts@prolunginc.com

Director of Marketing and Business Development

 

Investor relations information, contact:

Jennifer K. Zimmons, Ph.D.| +1-917-214-3514 | jzimmons@zimmonsic.com

Zimmons International Communications, Inc.

 

ProLung

757 E. South Temple Suite 150

Salt Lake City, Utah 84102

USA

www.prolunginc.com